It strives for building a highly stable and integrated industry chain in favor of global demands.
Looking at the world, Miedykol is committed to creating its industry chain at the core of medical grade plant-based polymers and synthetic APIs, improving its strength to satisfy the diverse needs for designed new drug delivery systems and high-class medication agents.
Supported by its American parent company——Mikem Chemical and driven by other sister companies, Miedykol has been concentrating on establishment of its own industrial chains in virtue of all available resources and advantages. Its final objective is to whereby forge a stable, strong and efficient chain highly integrated with raw material collection and processing, new product development and manufacturing, technology improvement and upgrading, and after-sale service and requirement response.
Stability &
Quality Are
Redline at Miedykol.
The factories have been set up adjacent to the place where provides the source of raw materials like cotton, bamboo, tuber crop and grain crop. Developing various logistics plans based on actual situations. ABC (Activity-based Costing System) is employed to exclusively account the logistics cost.
Miedykol has established the long-term partnership with multiple raw material suppliers. Meanwhile, it diversifies the supplying chains through finding multi-suppliers, multi-transportation channels, and locating multi-manufacturing bases in different places.
Miedykol has a stringent evaluation systems for its suppliers, including their industrial qualification, reputation, production capacity and quality certification. It has upheld the principle of “no certification, no cooperation”.
Miedykol R & D Strength and Its ESG Efforts
